These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8094785)

  • 21. Lorenzo's oil: advances in the treatment of neurometabolic disorders.
    Ferri R; Chance PF
    Arch Neurol; 2005 Jul; 62(7):1045-6. PubMed ID: 16009756
    [No Abstract]   [Full Text] [Related]  

  • 22. Lorenzo's oil and lymphocytopenia.
    Unkrig CJ; Schröder R; Scharf RE
    N Engl J Med; 1994 Feb; 330(8):577. PubMed ID: 8204158
    [No Abstract]   [Full Text] [Related]  

  • 23. The clinical course of childhood and adolescent adrenoleukodystrophy before and after Lorenzo's oil.
    Suzuki Y; Imamura A; Shimozawa N; Kondo N
    Brain Dev; 2001 Mar; 23(1):30-3. PubMed ID: 11226726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced lymphocyte proliferation in patients with adrenoleukodystrophy treated with erucic acid (22:1)-rich triglycerides.
    Pour RB; Stöckler-Ipsiroglu S; Hunneman DH; Gahr M; Korenke GC; Pabst W; Hanefeld F; Peters A
    J Inherit Metab Dis; 2000 Mar; 23(2):113-9. PubMed ID: 10801052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Lorenzo's oil. A realistic presentation of two parents' fight against adrenoleukodystrophy].
    Söderfeldt B
    Lakartidningen; 1993 May; 90(20):1969-72. PubMed ID: 8502039
    [No Abstract]   [Full Text] [Related]  

  • 26. Komrower Lecture. Adrenoleukodystrophy: natural history, treatment and outcome.
    Moser HW
    J Inherit Metab Dis; 1995; 18(4):435-47. PubMed ID: 7494402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the preventive effect of glyceryl trioleate-trierucate ("Lorenzo's oil") therapy in X-linked adrenoleukodystrophy: results of two concurrent trials.
    Moser HW; Raymond GV; Koehler W; Sokolowski P; Hanefeld F; Korenke GC; Green A; Loes DJ; Hunneman DH; Jones RO; Lu SE; Uziel G; Giros ML; Roels F
    Adv Exp Med Biol; 2003; 544():369-87. PubMed ID: 14713253
    [No Abstract]   [Full Text] [Related]  

  • 28. Decreased platelet membrane anisotropy in patients with adrenoleukodystrophy treated with erucic acid (22:1)-rich triglycerides.
    Stöckler S; Opper C; Greinacher A; Hunneman DH; Korenke GC; Unkrig CJ; Hanefeld F
    J Inherit Metab Dis; 1997 Mar; 20(1):54-8. PubMed ID: 9061568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Lorenzo's Oil on peroxisomes in healthy mice.
    De Craemer D; Van den Branden C; Fontaine M; Vamecq J
    Prostaglandins Other Lipid Mediat; 1998 Mar; 55(4):237-44. PubMed ID: 9644114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A happier sequel to Lorenzo's Oil?
    Wanders RJ
    Nat Med; 1998 Nov; 4(11):1245-6. PubMed ID: 9809546
    [No Abstract]   [Full Text] [Related]  

  • 31. Dietary treatment for X-linked adrenoleukodystrophy: is "Lorenzo's oil" useful?
    Prieto Tenreiro A; Penacho Lázaro MÁ; Andrés Celda R; Fernández Fernández M; González Mateo C; Díez Hernández A
    Endocrinol Nutr; 2013 Jan; 60(1):37-9. PubMed ID: 22622158
    [No Abstract]   [Full Text] [Related]  

  • 32. ['Lorenzo's oil'].
    Barth PG
    Ned Tijdschr Geneeskd; 1993 Mar; 137(13):640-1. PubMed ID: 8469294
    [No Abstract]   [Full Text] [Related]  

  • 33. Lipoid pneumonia as a complication of Lorenzo's oil therapy in a patient with adrenoleukodystrophy.
    Majori M; Scarascia A; Anghinolfi M; Pisi R; Gnetti L; Casalini AG
    J Bronchology Interv Pulmonol; 2014 Jul; 21(3):271-3. PubMed ID: 24992138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lorenzo's oil--hope and disappointment.
    Rizzo WB
    N Engl J Med; 1993 Sep; 329(11):801-2. PubMed ID: 8043042
    [No Abstract]   [Full Text] [Related]  

  • 35. Lorenzo's oil: a reassessment.
    Poulos A; Robertson EF
    Med J Aust; 1994 Mar; 160(6):315-7. PubMed ID: 8133809
    [No Abstract]   [Full Text] [Related]  

  • 36. Dietary erucic acid therapy for X-linked adrenoleukodystrophy.
    Rizzo WB; Leshner RT; Odone A; Dammann AL; Craft DA; Jensen ME; Jennings SS; Davis S; Jaitly R; Sgro JA
    Neurology; 1989 Nov; 39(11):1415-22. PubMed ID: 2682348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A mixture of oleic, erucic and conjugated linoleic acids modulates cerebrospinal fluid inflammatory markers and improve somatosensorial evoked potential in X-linked adrenoleukodystrophy female carriers.
    Cappa M; Bizzarri C; Petroni A; Carta G; Cordeddu L; Valeriani M; Vollono C; De Pasquale L; Blasevich M; Banni S
    J Inherit Metab Dis; 2012 Sep; 35(5):899-907. PubMed ID: 22189598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Giant platelets in erucic acid therapy for adrenoleukodystrophy.
    Stöckler S; Molzer B; Plecko B; Zenz W; Muntean W; Söling U; Hunneman DH; Korenke C; Hanefeld F
    Lancet; 1993 May; 341(8857):1414-5. PubMed ID: 8098819
    [No Abstract]   [Full Text] [Related]  

  • 39. More on Lorenzo's oil.
    Odone A; Odone M
    N Engl J Med; 1994 Jun; 330(26):1904-5. PubMed ID: 8196741
    [No Abstract]   [Full Text] [Related]  

  • 40. Improvement of clinical and MRI findings in a boy with adrenoleukodystrophy by dietary erucic acid therapy.
    Maeda K; Suzuki Y; Yajima S; Asano J; Yamaguchi S; Matsumoto N; Borel J; Moser HW; Orii T
    Brain Dev; 1992 Nov; 14(6):409-12. PubMed ID: 1492654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.